EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An immune-mediated effect of the antibiotic cefiderocol on LPS-induced acute lung injury

Min Hao iD, Ying Li, Yingmin Bi, Shuang Liu, Mohan Ju iD

Antimicrobial Agents and Chemotherapy · 2026

DOI: 10.1128/aac.01634-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Min Hao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Antibiotics, Huashan Hospital, Fudan University Shanghai, Shanghai, China. Hauptthemen laut MEDLINE: Acute Lung Injury, Lipopolysaccharides, Cephalosporins, Anti-Bacterial Agents. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Municipal Health Commission, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study examines the immune-modulatory effects of cefiderocol in a murine model of lipopolysaccharide (LPS)-induced acute lung injury (ALI). Cefiderocol pretreatment significantly reduced lung tissue damage, lowered pro-inflammatory cytokines, and decreased ferroptosis markers. Its protective effect was comparable to that of the ferroptosis inhibitor ferrostatin-1, while cefepime showed limited efficacy. These findings suggest that cefiderocol has an immuno-mediated role in LPS-induced ALI, potentially by modulating ferroptosis and inflammation, warranting further investigation for sepsis-related complications. IMPORTANCE This study examines the immune-modulatory effects of cefiderocol in a murine model of LPS-induced acute lung injury (ALI). Cefiderocol pretreatment significantly reduced lung tissue damage, lowered pro-inflammatory cytokines, and decreased ferroptosis markers. Its protective effect was comparable to that of the ferroptosis inhibitor ferrostatin-1, while cefepime showed limited efficacy. These findings suggest that cefiderocol has an immuno-mediated role in LPS-induced ALI, potentially by modulating ferroptosis and inflammation, warranting further investigation for sepsis-related complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Lung InjuryLipopolysaccharidesCephalosporinsAnti-Bacterial AgentsCefiderocolAnimalsMiceCefepimePhenylenediaminesCytokinesLungMaleDisease Models, AnimalCyclohexylamines

Stichwörter der Autor:innen

acute lung injurycefiderocolimmuno-mediated effectlipopolysaccharide

Substanzen

CefiderocolLipopolysaccharidesCephalosporinsAnti-Bacterial AgentsCefepimePhenylenediaminesferrostatin-1CytokinesCyclohexylamines

Autor:innen und Institutionen

  • Institute of Antibiotics, Huashan Hospital, Fudan University Shanghai, Shanghai, China.

ORCID-Profile: Min Hao, Mohan Ju

Förderung

  • Shanghai Municipal Health Commission
  • National Natural Science Foundation of China

Zitieren

APA

Hao, M., Li, Y., Bi, Y., Liu, S., & Ju, M. (2026). An immune-mediated effect of the antibiotic cefiderocol on LPS-induced acute lung injury. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01634-25

Vancouver

Hao M, Li Y, Bi Y, Liu S, Ju M. An immune-mediated effect of the antibiotic cefiderocol on LPS-induced acute lung injury. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.01634-25

BibTeX
@article{Hao2026,
  author = {Hao, Min and Li, Ying and Bi, Yingmin and Liu, Shuang and Ju, Mohan},
  title = {An immune-mediated effect of the antibiotic cefiderocol on LPS-induced acute lung injury},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  doi = {10.1128/aac.01634-25}
}
Kostenlos starten →